Archive for the ‘pharmaceuticals’ tag
Chart of the Day: How much healthcare is spent on pharmaceuticals?
Often misunderstood statistics is that less than 15% of healthcare funding in the US is spent on pharmaceuticals. A compelling international comparison chart from the Commonwealth Fund:
Protected: Potential for improvement in study start up: Sponsors
Chart of the Day: Probability of success of clinical trials
For pharma, this is the curve that needs to be re-shaped:
Source: Morgan Stanley
Chart of the Day: Where is clinical research happening (therapeutic areas)?
Most clinical research is happening in oncology, CNS, and cardiovascular:
Source: Company research via Barclays Capital
Chart of the Day: Where is the clinical research happening (phase)?
Pre-phase II R&D accounts for about 35% of total R&D spending:
Source: PhRMA, 2009
Chart of the Day: Segments of healthcare expenditures
In all the rhetoric of healthcare or health insurance reform (see recent NPR article on positioning), it is useful to remember what are the biggest “chunks” of healthcare expenditures. Is the healthcare debate focused on the right areas of expenditures? (From Kaiser.)
Chart of the Day: Is Pharma R&D spending producing results?
Chart from the Government Accountability Office 2006 report, showing that the number of NMEs has actually fallen while R&D spending has dramatically increased. In other words, the cost per NME has risen over time:
Chart of the day: Drug approval pipeline
Always nice to see helpful illustrations of the time required and probability of success of compounds receiving FDA approval:
It’s a reminder of TrialDox’s mission to minimize the time to complete clinical studies and get safe and effective products to the market faster.